Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
NCT00490191Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 1999
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 6
01
Overview
A Phase 4 trial of somatropin in growth hormone deficiency (GHD), sponsored by Eli Lilly and Company. Started Jan 1999; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00490191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490191.